Silence Therapeutics plc Net Assets Liabilities
Silence Therapeutics plc (SLN) had Net Assets Liabilities of GBP 17.05 million as of 2023-12-31, per its 20-F filed 2024-03-13.
Discontinued › Notes
ifrs-full:NetAssetsLiabilities · last filed 2024-03-13
- 2023-12-31: Net Assets Liabilities 17.05M GBP.
- 2022-12-31: Net Assets Liabilities 22.07M GBP.
- 2021-12-31: Net Assets Liabilities 8.53M GBP.
- 2020-12-31: Net Assets Liabilities 9.06M GBP.
| Period end | Net Assets Liabilities |
|---|---|
| 2023-12-31 | 17.05M GBP 20-F · filed 2024-03-13 |
| 2022-12-31 | 22.07M GBP 20-F · filed 2024-03-13 |
| 2021-12-31 | 8.53M GBP 20-F · filed 2023-03-15 |
| 2020-12-31 | 9.06M GBP 20-F · filed 2022-03-17 |
| 2019-12-31 | 20.91M GBP 20-F/A · filed 2021-04-29 |
| 2018-12-31 | 35.05M GBP 20-F/A · filed 2021-04-29 |